CLEC9A 抗体
(C-Type Lectin Domain Family 9, Member A (CLEC9A))
CLEC9A is a group V C-type lectin-like receptor (CTLR) that functions as an activation receptor and is expressed on myeloid lineage cells (Huysamen et al., 2008 [PubMed 18408006]).[supplied by OMIM, Aug 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| CLEC9A 抗体 (AA 103-214) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| CLEC9A 抗体 (CF®488A) | 小鼠 | 大鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 (CF®740) | 小鼠 | 大鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 (CF®770) | 小鼠 | 大鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 (CF®568) | 小鼠 | 大鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 (CF®647) | 小鼠 | 大鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 (CF®640R) | 小鼠 | 大鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 (CF®405S) | 小鼠 | 大鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 | 小鼠 | 大鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 (Biotin) | 小鼠 | 大鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 (CF®594) | 小鼠 | 大鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 (Biotin) | 人 | 小鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 (CF®594) | 人 | 小鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 (CF®488A) | 人 | 小鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 (CF®740) | 人 | 小鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 (CF®568) | 人 | 小鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 (CF®647) | 人 | 小鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 (CF®640R) | 人 | 小鼠 Monoclonal |
|
|
|
| CLEC9A 抗体 (Alexa Fluor 555) | 人 | 兔 Polyclonal |
|
|
|
| CLEC9A 抗体 (Alexa Fluor 680) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IF/ICC (Immunofluorescence (fixed cells): 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 103-214
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- Func (Functional Studies: 所列应用)
- 适用
- 小鼠
- 宿主
- 大鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1F6
- 标记
- CF®488A
- 抗体亚型
- IgG1, kappa
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- Func (Functional Studies: 所列应用)
- 适用
- 小鼠
- 宿主
- 大鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1F6
- 标记
- CF®740
- 抗体亚型
- IgG1, kappa
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- Func (Functional Studies: 所列应用)
- 适用
- 小鼠
- 宿主
- 大鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1F6
- 标记
- CF®770
- 抗体亚型
- IgG1, kappa
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- Func (Functional Studies: 所列应用)
- 适用
- 小鼠
- 宿主
- 大鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1F6
- 标记
- CF®568
- 抗体亚型
- IgG1, kappa
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- Func (Functional Studies: 所列应用)
- 适用
- 小鼠
- 宿主
- 大鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1F6
- 标记
- CF®647
- 抗体亚型
- IgG1, kappa
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- Func (Functional Studies: 所列应用)
- 适用
- 小鼠
- 宿主
- 大鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1F6
- 标记
- CF®640R
- 抗体亚型
- IgG1, kappa
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- Func (Functional Studies: 所列应用)
- 适用
- 小鼠
- 宿主
- 大鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1F6
- 标记
- CF®405S
- 抗体亚型
- IgG1, kappa
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- Func (Functional Studies: 所列应用)
- 适用
- 小鼠
- 宿主
- 大鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1F6
- 标记
- Biotin
- 抗体亚型
- IgG1, kappa
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- Func (Functional Studies: 所列应用)
- 适用
- 小鼠
- 宿主
- 大鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1F6
- 标记
- CF®594
- 抗体亚型
- IgG1, kappa
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 8F9
- 标记
- Biotin
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 8F9
- 标记
- CF®594
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 8F9
- 标记
- CF®488A
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 8F9
- 标记
- CF®740
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 8F9
- 标记
- CF®568
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 8F9
- 标记
- CF®647
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 8F9
- 标记
- CF®640R
- 抗体亚型
- IgG2a, kappa
Latest Publications for our CLEC9A 抗体
: "Defining human dendritic cell progenitors by multiparametric flow cytometry." in: Nature protocols, Vol. 10, Issue 9, pp. 1407-22, (2016) (PubMed).
: "Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non-human primates." in: European journal of immunology, Vol. 45, Issue 3, pp. 854-64, (2015) (PubMed).
: "Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 193, Issue 4, pp. 1622-35, (2014) (PubMed).
: "TLR3-responsive, XCR1+, CD141(BDCA-3)+/CD8α+-equivalent dendritic cells uncovered in healthy and simian immunodeficiency virus-infected rhesus macaques." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 192, Issue 10, pp. 4697-708, (2014) (PubMed).
: "Targeting DNGR-1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas." in: European journal of immunology, Vol. 44, Issue 7, pp. 1947-55, (2014) (PubMed).
: "Boosting antibody responses by targeting antigens to dendritic cells." in: Trends in immunology, Vol. 33, Issue 2, pp. 71-7, (2012) (PubMed).
: "Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A." in: European journal of immunology, Vol. 40, Issue 5, pp. 1255-65, (2010) (PubMed).
: "Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non-human primates." in: European journal of immunology, Vol. 45, Issue 3, pp. 854-64, (2015) (PubMed).
: "Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 193, Issue 4, pp. 1622-35, (2014) (PubMed).
: "TLR3-responsive, XCR1+, CD141(BDCA-3)+/CD8α+-equivalent dendritic cells uncovered in healthy and simian immunodeficiency virus-infected rhesus macaques." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 192, Issue 10, pp. 4697-708, (2014) (PubMed).
: "Targeting DNGR-1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas." in: European journal of immunology, Vol. 44, Issue 7, pp. 1947-55, (2014) (PubMed).
: "Boosting antibody responses by targeting antigens to dendritic cells." in: Trends in immunology, Vol. 33, Issue 2, pp. 71-7, (2012) (PubMed).
: "Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A." in: European journal of immunology, Vol. 40, Issue 5, pp. 1255-65, (2010) (PubMed).
Aliases for CLEC9A 抗体
C-type lectin domain family 9, member a (Clec9a) 抗体C-type lectin domain containing 9A (CLEC9A) 抗体
C-type lectin domain containing 9A (Clec9a) 抗体
C-type lectin domain family 9, member A (CLEC9A) 抗体
9830005G06Rik 抗体
DNGR-1 抗体
DNGR1 抗体
RGD1562513 抗体
UNQ9341 抗体
您还需要查找其他产品吗？
You are here:
